TMRC Co., Ltd. aims to provide CRO service (support for pharmaceutical development), as well as drugs development service (in-house development), engaged in cancers.
Company (Alive / Active)
Total Funding | Date of Last Funding | |
---|---|---|
TMRC | $0M | Oct 26, 2019 |
See all 15 competitors |
Per Week | Per Month | Per 6 Months | Per Year | |
---|---|---|---|---|
Rank | Login to see details | |||
Page Views Per Million | Login to see details | |||
Page Views Per User | Login to see details | |||
Reach Per Million | Login to see details |
Investor | Investor Type | Location | Participating Rounds |
---|
Title | Application Date | Patent Date | Status (Patent / Application) |
---|---|---|---|
Tamibarotene capsule preparation | Mar 28, 2008 | Aug 28, 2012 | Patent |
Cancer stem cell proliferation inhibitor | May 20, 2015 | Application |